Switching from Wegovy Injections to the New Weight Loss Pill: What to Expect
UK guide to switching from Wegovy (semaglutide) weekly injections to oral weight loss medication — timing, dose equivalence, and what to track.
Wegovy has been a weekly injection staple for UK weight management. As oral semaglutide options become more widely discussed, many patients ask whether switching from injections to a pill is straightforward — and what to expect during the transition.
Why people consider switching
Common reasons UK patients explore an oral alternative:
- Needle aversion — anxiety around weekly injections
- Travel convenience — pills are easier to transport than refrigerated pens
- Injection site issues — lipohypertrophy or recurring bruising
- Prescriber recommendation — based on tolerability or formulary changes
Switching is a clinical decision, not a DIY swap. Your GP or weight management clinic should guide timing and dosing.
What changes when you move to a pill
| Factor | Wegovy injection | Oral weight loss pill | |--------|-----------------|----------------------| | Frequency | Once weekly | Typically daily | | Storage | Refrigerated | Room temperature (check label) | | Absorption | Subcutaneous | Oral — timing with food/water matters | | Dose unit | mg per injection | mg per tablet (not equivalent) |
There is no direct conversion between injectable semaglutide mg and oral tablet strength. Your prescriber will start you at an appropriate oral dose — often lower than you might expect — and titrate based on tolerance.
The first four weeks after switching
Side effects can re-emerge even if you tolerated injections well:
- Nausea (most common in weeks 1–2)
- Constipation or loose stools
- Reduced appetite — may feel different from injection timing
- Fatigue during dose adjustment
Log symptoms daily. A simple 0–3 severity scale helps your clinician spot patterns quickly.
Weight tracking during the transition
Continue weekly weigh-ins using kg or stones — consistency matters more than the unit. Expect weight to fluctuate 1–2 kg during the switch period; focus on the four-week trend rather than day-to-day changes.
Mounjaro KwikPen users
If you are on Mounjaro rather than Wegovy, the injection-to-pill conversation differs — tirzepatide and semaglutide are distinct molecules. See our KwikPen dosing guide for injection-specific guidance.
Keep one timeline
Whether you inject or take a pill, one continuous log makes clinician appointments easier. GLPPal tracks injections, oral doses, appetite, weight and side effects on a single timeline — download on the App Store.
